Genetics of Behçet's disease

Behçet's Syndrome

Volumn , Issue , 2010, Pages 265-276

  Gül, Ahmet ^a   Ohno, Shigeaki ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Beh et's disease; Familial aggregation; Genomewide association study; HLA A26; HLA B51; Linkage study; MICA; Sibling recurrence risk ratio ( s)

Indexed keywords

EID: 84857119956     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-5641-5_15     Document Type: Chapter

References (119)

1. Gül A (2001) Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 19(Suppl 24):S6-S12
2. Zierhut M, Mizuki N, Ohno S et al (2003) Immunology and functional genomics of Behçet's disease. Cell Mol Life Sci 60:1903-1922
3. Fowler TJ, Humpston DJ, Nussey AM, Small M (1968) Behçet's syndrome with neurological manifestations in two sisters. Br Med J 2:473-474
4. Mason RM, Barnes CG (1969) Behçet's syndrome with arthritis. Ann Rheum Dis 28:95-103
5. Fadli ME, Youssef MM (1973) Neuro-Behçet's syndrome in the United Arab Republic. Eur Neurol 9:76-89
6. Chajek T, Fainaru M (1975) Behçet's disease: report of 41 cases and a review of the literature. Medicine (Baltimore) 54:179-196
7. Goolamali SK, Comaish JS, Hassanyeh F (1976) Familial Behçet's syndrome. Br J Dermatol 95:637-642
8. Nahir M, Scharf Y, Gidoni O et al (1978) HL-A antigens in Behçet's disease. A family study. Dermatologica 156:205-208 (Pubitemid 8272389)
9. Abdel-Aziz AH, Fairburn EA (1978) Familial Behçet's syndrome. Cutis 21:649-652
10. Dündar SV, Gencalp U, Simsek H (1985) Familial cases of Behçet's disease. Br J Dermatol 113:319-321
11. Chajek-Shaul T, Pisanty S, Knobler H et al (1987) HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome. Am J Med 83:666-672
12. Akpolat T, Koc Y, Yeniay I et al (1992) Familial Behçet's disease. Eur J Med 1:391-395
13. Villanueva JL, Gonzalez-Dominguez J, Gonzalez-Fernandez R et al (1993) HLA antigen familial study in complete Behçet's syndrome affecting three sisters. Ann Rheum Dis 52:155-157 (Pubitemid 23065678)
14. Nishiura K, Kotake S, Ichiishi A, Matsuda H (1996) Familial occurrence of Behçet's disease. Jpn J Ophthalmol 40:255-259
15. Nishiyama M, Nakae K, Umehara T (2001) A study of familial occurrence of Behçet's disease with and without ocular lesions. Jpn J Ophthalmol 45:313-316 (Pubitemid 32458007)
16. Fietta P (2005) Behçet's disease: familial clustering and immunogenetics. Clin Exp Rheumatol 23(Suppl 38):S96-S105
17. Gül A, Inanc M, Ocal L et al (2000) Familial aggregation of Behçet's disease in Turkey. Ann Rheum Dis 59:622-625 (Pubitemid 30617087)
18. Treudler R, Orfanos CE, Zouboulis CC (1999) Twenty-eight cases of juvenile-onset Adamantiades-Behçet's disease in Germany. Dermatology 199:15-19 (Pubitemid 29366781)
19. Koné-Paut I, Geisler I, Wechsler B et al (1999) Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands. J Pediatr 135:89-93 (Pubitemid 30180568)
20. Hayasaka S, Kurome H, Noda S (1994) HLA antigens in a Japanese family with Behçet's disease. Graefes Arch Clin Exp Ophthalmol 232:589-590 (Pubitemid 24280285)
21. Nishiyama M, Nakae K, Kuriyama T et al (2002) A study among related pairs of Japanese patients with familial Behçet's disease: group comparisons by interval of disease onsets. J Rheumatol 29:743-747 (Pubitemid 34303868)
22. Aronsson A, Tegner E (1983) Behçet's syndrome in two brothers. Acta Derm Venereol 63:73-74
23. Fresko I, Soy M, Hamuryudan V et al (1998) Genetic anticipation in Behçet's syndrome. Ann Rheum Dis 57:45-48
24. Hamuryudan V, Yurdakul S, Ozbakir F et al (1991) Monozygotic twins concordant for Behçet's syndrome. Arthritis Rheum 34:1071-1072
25. Gül A, Inanç M, Ocal L et al (1997) HLA-B51 negative monozygotic twins discordant for Behçet's disease. Br J Rheumatol 36:922-923 (Pubitemid 27394070)
26. Kobayashi T, Sudo Y, Okamura S et al (2005) Monozygotic twins concordant for intestinal Behçet's disease. J Gastroenterol 40:421-425
27. Verity DH, Marr JE, Ohno S et al (1999) Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54:213-220 (Pubitemid 29443840)
28. Ohno S, Ohguchi M, Hirose S et al (1982) Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 100:1455-1458 (Pubitemid 12055531)
29. Ono S, Aoki K, Sugiura S et al (1973) HL-A5 and Behçet's disease. Lancet 2:1383-1384
30. Ono S, Nakayama E, Sugiura S et al (1975) Specific histocompatibility antigens associated with Behçet's disease. Am J Ophthalmol 80:636-641
31. Kilmartin DJ, Finch A, Acheson RW (1997) Primary association of HLA-B51 with Behçet's disease in Ireland. Br J Ophthalmol 81:649-653
32. Ambresin A, Tran T, Spertini F, Herbort C (2002) Behçet's disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 10:53-63 (Pubitemid 36042847)
33. Pipitone N, Boiardi L, Olivieri I et al (2004) Clinical manifestations of Behçet's disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol 22(Suppl 36):S46-S51
34. Bettencourt A, Pereira C, Carvalho L et al (2008) New insights of HLA class I association to Behçet's disease in Portuguese patients. Tissue Antigens 72:379-382
35. Sano K, Yabuki K, Imagawa Y et al (2001) The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease. Tissue Antigens 58:77-82 (Pubitemid 33020620)
36. * 510101 associated with Behçet's disease. Tissue Antigens 72:347-353
37. Arber N, Klein T, Meiner Z et al (1991) Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome. Ann Rheum Dis 50:351-353
38. Sugisaki K, Saito R, Takagi T et al (2005) HLA-B52-positive vasculo-Behçet's disease: usefulness of magnetic resonance angiography, ultrasound study, and computed tomographic angiography for the early evaluation of multiarterial lesions. Mod Rheumatol 15:56-61 (Pubitemid 40298425)
39. Falk K, Rötzschke O, Takiguchi M et al (1995) Peptide motifs of HLA-B51,-B52 and-B78 molecules, and implications for Behçet's disease. Int Immunol 7:223-228
40. * 5101 molecules. Immunogenetics 46:245-248 (Pubitemid 27292367)
41. *5101 and the linkage to Behçet's disease. In: Zierhut M, Ohno S (eds) Immunology of Behçet's disease. Swets & Zeitlinger, Lisse, pp 127-137
42. * 5101. Am J Ophthalmol 116:406-409 (Pubitemid 23299483)
43. *5108 with Behçet's disease in Greek patients. Tissue Antigens 59:118-121 (Pubitemid 34620552)
44. Pirim I, Atasoy M, Ikbal M et al (2004) HLA class I and class II genotyping in patients with Behçet's disease: a regional study of eastern part of Turkey. Tissue Antigens 64:293-297 (Pubitemid 39120456)
45. *5108, and lack of association of class II alleles with Behçet's disease in Italian patients. Tissue Antigens 54:565-571 (Pubitemid 30026018)
46. Yabuki K, Ohno S, Mizuki N et al (1999) HLA class I and II typing of the patients with Behçet's disease in Saudi Arabia. Tissue Antigens 54:273-277 (Pubitemid 29443847)
47. Yasuoka H, Okazaki Y, Kawakami Y et al (2004) Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease. Arthritis Rheum 50:3658-3662 (Pubitemid 39488694)
48. Martin MP, Gao X, Lee J-H et al (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31:429-434 (Pubitemid 35154456)
49. *2702 with Behçet's disease. Genes Immun 3:368-372 (Pubitemid 38967565)
50. Duymaz-Tozkir J, Uyar A, Norman PJ et al (2008) Distribution of killer immunoglobulinlike receptor 3DL1/3DS1 alleles in Behçet's disease. Arthritis Rheum 58(Suppl):S855
51. Wildner G, Thurau SR (1994) Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol 24:2579-2585 (Pubitemid 24342169)
52. Kurhan-Yavuz S, Direskeneli H, Bozkurt N et al (2000) Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis. Clin Exp Immunol 120:162-166 (Pubitemid 30176914)
53. Hill A, Takiguchi M, McMichael A (1993) Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the alpha 2 domain. Immunogenetics 37:95-101
54. Turner MJ, Sowders DP, DeLay ML et al (2005) HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 175:2438-2448 (Pubitemid 41113854)
55. Takeno M, Kariyone A, Yamashita N et al (1995) Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 38:426-433
56. Sensi A, Gavioli R, Spisani S et al (1991) HLA B51 antigen associated with neutrophil hyper-reactivity. Dis Markers 9:327-331
57. Taurog JD, Maika SD, Satumtira N et al (1999) Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 169:209-223 (Pubitemid 29338734)
58. Gül A, Hajeer AH, Worthington J et al (2001) Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 44(1):239-240 (Pubitemid 32113140)
59. Miretti MM, Walsh EC, Ke X et al (2005) A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 76:634-646 (Pubitemid 40432170)
60. Mizuki N, Ota M, Kimura M et al (1997) Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet's disease. Proc Natl Acad Sci U S A 94:1298-1303
61. Hughes EH, Collins RW, Kondeatis E et al (2005) Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behçet's disease in Caucasian patients. Tissue Antigens 66:195-199 (Pubitemid 41243307)
62. Mizuki N, Meguro A, Tohnai I et al (2007) Association of major histocompatibility complex Class I chain-related Gene A and HLA-B alleles with Behçet's disease in Turkey. Jpn J Ophthalmol 51:431-436
63. Mizuki N, Ota M, Yabuki K et al (2000) Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 41:3702-3708
64. Mizuki N, Ohno S, Tanaka H et al (1992) Association of HLA-B51 and lack of association of class II alleles with Behçet's disease. Tissue Antigens 40:22-30
65. Mizuki N, Ohno S, Ando H et al (1996) HLA-C genotyping of patient with Behçet's disease in the Japanese population. Hum Immunol 50:47-53 (Pubitemid 26282610)
66. *1602: a new susceptibility marker of Behçet's disease in southern Spain. Tissue Antigens 51:111-114 (Pubitemid 28014553)
67. *010101 reduce the risk of Behçet's disease. Tissue Antigens 69:139-144 (Pubitemid 46174868)
68. Meguro A, Inoko H, Ota M, et al (2009) Genetics of Behçet's disease inside and outside the MHC. Ann Rheum Dis 69:747-754
69. Ahmad T, Wallace GR, James T et al (2003) Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 48:807-813 (Pubitemid 36302019)
70. Akman A, Sallakci N, Coskun M et al (2006) TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease. Br J Dermatol 155:350-356 (Pubitemid 44050569)
71. Park K, Kim N, Nam J et al (2006) Association of TNFA promoter region haplotype in Behçet's disease. J Korean Med Sci 21:596-601 (Pubitemid 44199310)
72. Kamoun M, Chelbi H, Houman MH et al (2007) Tumor necrosis factor gene polymorphisms in Tunisian patients with Behçet's disease. Hum Immunol 68:201-205 (Pubitemid 46356652)
73. Karasneh J, Hajeer AH, Barrett J et al (2003) Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behçet's disease. Rheumatology (Oxford) 42:860-864 (Pubitemid 37220935)
74. Chang HK, Jang WC, Park SB et al (2005) Association between interleukin 6 gene polymorphisms and Behçet's disease in Korean people. Ann Rheum Dis 64:339-340 (Pubitemid 40193648)
75. Lee EB, Kim JY, Zhao J et al (2007) Haplotype association of IL-8 gene with Behçet's disease. Tissue Antigens 69:128-132 (Pubitemid 46174866)
76. Wallace GR, Kondeatis E, Vaughan RW et al (2007) IL-10 genotype analysis in patients with Behçet's disease. Hum Immunol 68:122-127 (Pubitemid 46282216)
77. Yanagihori H, Oyama N, Nakamura K et al (2006) Role of IL-12B promoter polymorphism in Adamantiades-Behçet's disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen. J Invest Dermatol 126:1534-1540
78. Jang WC, Nam YH, Ahn YC et al (2008) Interleukin-17F gene polymorphisms in Korean patients with Behçet's disease. Rheumatol Int 29:173-178
79. Lee YJ, Kang SW, Park JJ et al (2006) Interleukin-18 promoter polymorphisms in patients with Behçet's disease. Hum Immunol 67:812-818 (Pubitemid 44572598)
80. Mojtahedi Z, Ahmadi SB, Razmkhah M et al (2006) Association of chemokine receptor 5 (CCR5) delta32 mutation with Behçet's disease is dependent on gender in Iranian patients. Clin Exp Rheumatol 24(Suppl 42):S91-S94 (Pubitemid 44696886)
81. Ateş O, Dalyan L, Hatemi G et al (2009) Genetic susceptibility to Behçet's syndrome is associated with NRAMP1 (SLC11A1) polymorphism in Turkish patients. Rheumatol Int 29:787-791
82. Kim SK, Jang WC, Park SB et al (2006) SLC11A1 gene polymorphisms in Korean patients with Behçet's disease. Scand J Rheumatol 35:398-401 (Pubitemid 44601076)
83. Ben Dhifallah I, Chelbi H, Braham A et al (2009) CTLA-4 +49A/G polymorphism is associated with Behçet's disease in a Tunisian population. Tissue Antigens 73(3):213-217
84. Park KS, Baek JA, Do JE et al (2009) CTLA4 gene polymorphisms and soluble CTLA4 protein in Behçet's disease. Tissue Antigens 74:222-227
85. Wang H, Nakamura K, Inoue T et al (2004) Mannose-binding lectin polymorphisms in patients with Behçet's disease. J Dermatol Sci 36:115-117 (Pubitemid 39424137)
86. Park KS, Min K, Nam JH et al (2005) Association of HYPA haplotype in the mannosebinding lectin gene-2 with Behçet's disease. Tissue Antigens 65:260-265 (Pubitemid 40342432)
87. Chen X, Katoh Y, Nakamura K et al (2006) Single nucleotide polymorphisms of Ficolin 2 gene in Behçet's disease. J Dermatol Sci 43:201-205 (Pubitemid 44189200)
88. Hou S, Yang P, Du L et al (2008) SUMO4 gene polymorphisms in Chinese Han patients with Behçet's disease. Clin Immunol 129:170-175
89. Li K, Zhao M, Hou S, Du L et al (2008) Association between polymorphisms of FCRL3, a non-HLA gene, and Behçet's disease in a Chinese population with ophthalmic manifestations. Mol Vis 14:2136-2142
90. Seo J, Park JS, Nam JH et al (2007) Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behçet's disease. Tissue Antigens 70:307-313 (Pubitemid 47340735)
91. Baranathan V, Stanford MR, Vaughan RW et al (2007) The association of the PTPN22 620W polymorphism with Behçet's disease. Ann Rheum Dis 66:1531-1533 (Pubitemid 350032665)
92. Gunesacar R, Erken E, Bozkurt B et al (2007) Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behçet's disease. Int J Immunogenet 34:45-49 (Pubitemid 46232341)
93. Meguro A, Ota M, Katsuyama Y et al (2008) Association of the toll-like receptor 4 gene polymorphisms with Behçet's disease. Ann Rheum Dis 67:725-727 (Pubitemid 351571945)
94. Horie Y, Meguro A, Ota M et al (2009) Association of TLR4 polymorphisms with Behçet's disease in a Korean population. Rheumatology (Oxford) 48:638-642
95. Touitou I, Magne X, Molinari N et al (2000) MEFV mutations in Behçet's disease. Hum Mutat 16:271-272
96. Atagunduz P, Ergun T, Direskeneli H (2003) MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 21(Suppl 30):S35-S37 (Pubitemid 37193095)
97. Imirzalioglu N, Dursun A, Tastan B et al (2005) MEFV gene is a probable susceptibility gene for Behçet's disease. Scand J Rheumatol 34:56-58 (Pubitemid 40445060)
98. Rabinovich E, Shinar Y, Leiba M et al (2007) Common FMF alleles may predispose to development of Behçet's disease with increased risk for venous thrombosis. Scand J Rheumatol 36:48-52 (Pubitemid 46572912)
99. Ayesh S, Abu-Rmaileh H, Nassar S et al (2008) Molecular analysis of MEFV gene mutations among Palestinian patients with Behçet's disease. Scand J Rheumatol 37:370-374
100. Amoura Z, Dodé C, Hue S et al (2005) Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease. Arthritis Rheum 52:608-611 (Pubitemid 40216326)
101. Verity DH, Vaughan RW, Kondeatis E et al (2000) Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease. Eur J Immunogenet 27:73-76 (Pubitemid 30213950)
102. Boiardi L, Salvarani C, Casali B et al (2001) Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease. J Rheumatol 28:1283-1287 (Pubitemid 32510499)
103. Kim EH, Mok JW, Bang DS et al (2003) Intercellular adhesion molecule-1 polymorphisms in Korean patients with Behçet's disease. J Korean Med Sci 18:415-418 (Pubitemid 38021770)
104. Chmaisse HN, Fakhoury HA, Salti NN, Makki RF (2006) The ICAM-1 469 T/C gene polymorphism but not 241 G/A is associated with Behçet's disease in the Lebanese population. Saudi Med J 27:604-607
105. Salvarani C, Boiardi L, Casali B et al (2002) Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol 29:535-540 (Pubitemid 34202824)
106. Kim JU, Chang HK, Lee SS et al (2003) Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis. Ann Rheum Dis 62:1083-1087 (Pubitemid 37323573)
107. Karasneh JA, Hajeer AH, Silman A et al (2005) Polymorphisms in the endothelial nitric oxide synthase gene are associated with Behçet's disease. Rheumatology (Oxford) 44:614-617 (Pubitemid 41487229)
108. Ben Dhifallah I, Houman H, Khanfir M, Hamzaoui K (2008) Endothelial nitric oxide synthase gene polymorphism is associated with Behçet's disease in Tunisian population. Hum Immunol 69:661-665
109. Gül A, Ozbek U, Oztürk C et al (1996) Coagulation factor V gene mutation increases the risk of venous thrombosis in Behçet's disease. Br J Rheumatol 35:1178-1180
110. Verity DH, Vaughan RW, Madanat W et al (1999) Factor V Leiden mutation is associated with ocular involvement in Behçet's disease. Am J Ophthalmol 128(3):352-356 (Pubitemid 29413233)
111. Mammo L, Al-Dalaan A, Bahabri SS, Saour JN (1997) Association of factor V Leiden with Behçet's disease. J Rheumatol 24:2196-2198 (Pubitemid 27474043)
112. Gül A, Aslantas AB, Tekinay T et al (1999) Procoagulant mutations and venous thrombosis in Behçet's disease. Rheumatology (Oxford) 38:1298-1299
113. Ricart JM, Vayá A, Todolí J et al (2006) Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events. Thromb Haemost 95(4):618-624
114. Nakao K, Isashiki Y, Sonoda S et al (2007) Nitric oxide synthase and superoxide dismutase gene polymorphisms in Behçet's disease. Arch Ophthalmol 125:246-251
115. Tursen U, Tamer L, Api H et al (2007) Cytochrome P450 polymorphisms in patients with Behçet's disease. Int J Dermatol 46:153-156 (Pubitemid 46671690)
116. Yen JH, Tsai WC, Lin CH et al (2004) Cytochrome P450 1A1 and manganese superoxide dismutase gene polymorphisms in Behçet's disease. J Rheumatol 31:736-740
117. Tamer L, Tursen U, Eskandari G et al (2005) N-acetyltransferase 2 polymorphisms in patients with Behçet's disease. Clin Exp Dermatol 30:56-60 (Pubitemid 40188320)
118. Karasneh J, Gül A, Ollier WE et al (2005) Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis Rheum 52:1836-1842 (Pubitemid 40852892)
119. Gül A, Hajeer AH, Worthington J et al (2001) Linkage mapping of a novel susceptibility locus for Behçet's disease to chromosome 6p22-23. Arthritis Rheum 44:2693-2696 (Pubitemid 33049347)